title: Reply to the editorial on the HiLo trial.
authors.forename: V
authors.initials: V
authors.lastname: Gill
authors.forename: G
authors.initials: G
authors.lastname: Gerrard
authors.forename: G
authors.initials: G
authors.lastname: Radhakrishna
authors.forename: Z
authors.initials: Z
authors.lastname: Khan
authors.forename: D
authors.initials: D
authors.lastname: Williamson
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D013964:Thyroid Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D013965:Thyroidectomy; D013972:Thyrotropin / Q000008:administration & dosage
chemical_list: D007457:Iodine Radioisotopes; D013972:Thyrotropin